UK-headquartered investment & operating platform

Commercial returns from the industries that decide what Britain can build.

Reactors. Runways. Fabs. Grid connections. Nebula Group is a UK-headquartered investment and operating platform. We underwrite for returns first, and we look for them in the sectors where British science, engineering and industry already hold a real advantage.

Where we look Start a conversation

The mandate

Four tests every investment has to pass.

The commercial case is the first gate, not the last. We are investor and operator both – governance, sector expertise and people who have run the business in front of us. All four tests, not three. Fail one and we say so in week one.

01 – Return

Commercial performance

Risk-adjusted returns from durable businesses and productive assets. The commercial case is the first gate, not the last.

02 – Capability

UK capability

Sectors where long capital unlocks science, infrastructure and industrial capacity that would otherwise stall – or leave.

03 – Place

Regional growth

Skilled jobs, supply chains, regeneration. Weighted hard towards everywhere that is not London and the South East.

04 – Horizon

Enduring platforms

Operating capability that outlives us. Not passive exposure that leaves nothing behind.

Where we look

Eight sectors, one common thread.

Eight fields where Britain already holds real strength, and where patience rather than insight is the binding constraint. Open any one for the underwriting view: why the sector is hard, and the three things we check before we go further.

NG-01

Clean and secure energy

Generation, storage and network assets that hold their value across political and price cycles.

A grid queue and a first-of-a-kind build can outlast an entire fund before the asset produces a megawatt. We want revenue contracted far enough out to underwrite, and economics with a floor that survives a change of government.

What we look for
Contracted or regulated revenue
A credible grid or offtake route
Security-of-supply relevance

NG-02

Infrastructure and logistics

The physical layer beneath everything else: movement, storage, connection and the land they sit on.

Infrastructure rewards owners, not traders. The return comes from utilisation, from the difficulty of building a second one next door, and from value accruing quietly in land and permissions.

What we look for
Hard-to-replicate position
Utilisation upside under new ownership
Long-dated tenancy or usage

NG-03

Advanced manufacturing and materials

Processes and materials that are difficult to copy and harder still to relocate once established.

Process knowledge is the most under-priced asset in British industry. It lives in a line, a team and a set of tolerances that took years to settle – and it does not travel well. Which is exactly why we want it.

What we look for
Qualified into customer supply chains
Advantage in process, not marketing
Deferred capex with a clear payback

NG-04

Aviation and space

Airframes, uncrewed systems, launch and the ground segment that makes any of it commercially useful.

World-class engineering talent, and a thin pool of capital willing to fund it through certification. Uncrewed systems sit in the gap between a research grant and a procurement cycle. We back the whole stack – including the unglamorous ground segment, where the recurring revenue lives.

What we look for
A route through certification
Recurring revenue, not one-off programmes
Dual civil and defence relevance

NG-05

Digital and AI systems

Compute, data infrastructure and applied systems built on a defensible technical core rather than a wrapper.

We are sceptical of anything that loses its edge when the model underneath it upgrades. The interesting layer is beneath: compute, power, land, hard-won data, and systems welded so far into a regulated workflow that replacing them is a project, not a decision.

What we look for
Proprietary or hard-won data
Embedded in a regulated workflow
Power and land secured, not assumed

NG-06

Healthcare and life sciences

Data-rich precision medicine, discovery platforms and the clinical execution that turns insight into assets.

Science, talent, trials and markets sit across borders. We want platforms with a repeatable path from biological insight to validated asset – not businesses that stop at selling a tool. Clinical execution is something you partner for, not something a balance sheet substitutes.

What we look for
A repeatable path to validated assets
Clinical and regulatory partners in place
IP stewardship with a UK anchor

NG-07

Housing and property

Homes and mixed-use regeneration in places with unmet demand and a credible route to delivery.

Planning is the real variable, so we price it rather than assume it away. Structural demand, a genuine local relationship, a team that has finished something comparable. Regeneration only counts if it still stands up commercially in year ten.

What we look for
Structural, not speculative, demand
A delivery team with a finished comparable
Consenting risk priced, not ignored

NG-08

Finance and venture platforms

Selected lending, structured finance and early-stage platforms that support the rest of the group.

The least glamorous line, and the most useful. It funds our own delivery, bridges timing gaps and keeps us at the table when a project moves faster than an institution can. Selected venture positions give early sight of what matters to the industrial platforms later.

What we look for
Funds group delivery, not just returns
Discipline in credit and structuring
Early sight of relevant technology

Britain

A British base, because it pays.

Nebula is headquartered in Manchester, not London, and that is a position rather than an accident. The industrial base we invest behind is largely outside the South East, and so is most of the capacity that a serious industrial strategy has to rebuild.

A British base has to pay for itself. We take one where proximity is worth something commercially – to a cluster, a regulator, a workforce, a grid connection, a university department – and not where it merely flatters.

The United Kingdom is the centre of the strategy, not the boundary of it. Intellectual property, specialist teams, supply chains and customers sit across borders, so a share of what we do is cross-border by design. What does not move is the test: a real commercial outcome, and lasting value that stays in this country.

Headquartered in Manchester Weighted beyond London and the South East UK headquarters, R&D and manufacturing IP stewardship held in the UK Skilled employment and supply chain

Governance

Approval sits apart from origination.

Capital is introduced and held at group level, which retains treasury control and capital allocation authority wherever funds are operationally deployed. Every material commitment is approved centrally, and the people who find an opportunity do not sign it off.

Central capital allocation

Treasury and capital allocation authority are retained at group level, wherever funds are operationally held.

Approval separated from origination

Material investment decisions are approved centrally, by people other than those who sourced them.

Investment Committee

Group directors sitting with non-executive advisers and the sector specialists relevant to the transaction under review.

Arm’s length internally

Services and assets shared between group entities are priced on commercial terms, with costs and revenues allocated transparently.

How we operate

Our view

Britain rarely runs out of ideas. It runs out of patience – usually somewhere between the prototype and the second factory.

The research is strong. The engineering is strong. The patience is what runs out – through consenting, through a first-of-a-kind build, through a decade-long offtake.

So assets get sold the moment they turn interesting. Teams get bought out from abroad. Value that should have compounded here compounds somewhere else. Not dramatic – just a reasonable decision by an investor whose fund ends before the asset matures.

Our answer is structural, not sentimental. Dedicated vehicles instead of a fixed-life fund, so no exit clock sets the strategy. Operators on the boards. A British base because it pays – proximity to a cluster, a regulator, a workforce, a grid connection – not because it flatters.

And a straight trade. Patient capital is not cheap capital. Own something for ten years and you underwrite it ten times harder on day one.

A commercial return, and a Britain that can still build.

If you are building something that needs an owner rather than a counterparty, we would like to hear about it.

Start a conversation